Cargando…
Efficacy and safety of cyclosporine A treatment in autoimmune cytopenias: the experience of two Italian reference centers
BACKGROUND: Immune thrombocytopenia (ITP) and autoimmune hemolytic anemia (AIHA) show good responses to frontline steroids. About two-third of cases relapse and require second-line treatment, including rituximab, mainly effective in AIHA, and thrombopoietin-receptor agonists (TPO-RAs) in ITP, while...
| Autores principales: | , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
SAGE Publications
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9109490/ https://www.ncbi.nlm.nih.gov/pubmed/35585968 http://dx.doi.org/10.1177/20406207221097780 |